Birinapant
98%
- Product Code: 124708
CAS:
1260251-31-7
| Molecular Weight: | 806.94 g./mol | Molecular Formula: | C₄₂H₅₆F₂N₈O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
Birinapant is primarily investigated for its potential in cancer therapy, particularly in targeting and inducing apoptosis in cancer cells. It functions as a SMAC mimetic, which means it inhibits inhibitor of apoptosis proteins (IAPs), leading to the activation of cell death pathways in malignant cells. This mechanism is especially promising in treating cancers that are resistant to conventional therapies. Additionally, birinapant has shown potential in enhancing the efficacy of other treatments, such as chemotherapy and radiation, by sensitizing tumor cells to these therapies. Research is also exploring its role in combination with immunotherapies to boost the immune system's ability to fight cancer. Its application extends to preclinical studies for various cancers, including hematologic malignancies and solid tumors, making it a candidate for future targeted cancer treatments.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿7,632.00 |
+
-
|
| 0.025 | 10-20 days | ฿22,878.00 |
+
-
|
Birinapant
Birinapant is primarily investigated for its potential in cancer therapy, particularly in targeting and inducing apoptosis in cancer cells. It functions as a SMAC mimetic, which means it inhibits inhibitor of apoptosis proteins (IAPs), leading to the activation of cell death pathways in malignant cells. This mechanism is especially promising in treating cancers that are resistant to conventional therapies. Additionally, birinapant has shown potential in enhancing the efficacy of other treatments, such as chemotherapy and radiation, by sensitizing tumor cells to these therapies. Research is also exploring its role in combination with immunotherapies to boost the immune system's ability to fight cancer. Its application extends to preclinical studies for various cancers, including hematologic malignancies and solid tumors, making it a candidate for future targeted cancer treatments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :